Around one in four adults, and nearly one in five children have a seasonal allergy, according to 2021 statistics from the Centers for Disease Control and Prevention.
The Global Allergy Immunotherapy Market Size was valued at USD 2.0 billion in 2021 and the worldwide allergy immunotherapy market share is expected to.